University of Florida and Cyntellect Collaborate to Unlock Mysteries of Cancer Stem Cells

In situ processing by LEAP system to enable novel experiments with

26-Nov-2008 - Cyntellect announced that it has entered a research collaboration agreement with theUniversity of Florida Interdisciplinary Center for Biotechnology Research. The agreement will focus on a variety of research areas including the purification and analysis of cancer stem cells (CSCs), rare cells ...

Cyntellect Awarded $1.3MM Phase II SBIR Grant to Automate Cloning of Cells Based on Protein Secretion

16-May-2007 - Cyntellect, Inc. announced it will receive approximately $1.3MM in funding under a Phase II Small Business Innovative Research (SBIR) grant for continued new application development on its laser-based LEAP(TM) system. Specifically, the grant will fund further development of applications using ...

Cyntellect Appoints Drs. Alan Aderem, Charles Cantor and Michael Hanley to Its Scientific Advisory Board

New members to foster expanded applications of cell-based manipulation from functional proteomics to stem cells

30-Jan-2007 - Cyntellect, Inc. announced that it has appointed Drs. Alan Aderem, Charles Cantor and Michael Hanley to its Scientific Advisory Board (SAB). These three scientists along with the company's scientific founder, Dr. Bernhard Palsson, form an industry-seasoned Scientific Advisory Board to foster new, ...

Daiichi Enters Funded Research Agreement With Cyntellect

01-Apr-2005 - Cyntellect, Inc., a privately-held biotechnology company, announced the company has entered into a research agreement with Daiichi Pharmaceutical Co., Ltd. ("Daiichi") to utilize Cyntellect's high-throughput cell imaging and laser-based cell manipulation technology, LEAP(TM), for novel drug ...